Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 30 institutions that hold shares in the stock, with a total of 931,659 shares, which have been reported (via 13F filing form) to have a value of $1.49 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
K2 Principal Fund, L.P.
Toronto, A6 |
Nov 15, 2024 Q3 2024 |
209,266
shares
|
$334,825
0.19% of portfolio
|
Q3 2024
Reduced 36.1%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
192,387
shares
|
$307,819
0.0% of portfolio
|
Q2 2024
Added 10.19%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
168,200
shares
|
$269,120
0.0% of portfolio
|
Q3 2024
Reduced 4.76%
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
92,087
shares
|
$147,339
7.31% of portfolio
|
Q3 2023
Reduced 66.75%
|
|
|
Equitec Proprietary Markets, LLC
|
Oct 18, 2024 Q3 2024 |
82,727
shares
|
$132,363
0.17% of portfolio
|
Q3 2023
Added 34.7%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
49,700
shares
|
$79,520
0.0% of portfolio
|
Q3 2024
Added 2.47%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
35,228
shares
|
$56,364
0.0% of portfolio
|
Q3 2024
Reduced 35.76%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
27,601
shares
|
$44,161
0.0% of portfolio
|
Q3 2024
Added 7.83%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
25,900
shares
|
$41,440
0.0% of portfolio
|
Q3 2024
Added 9.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
19,208
shares
|
$30,732
0.0% of portfolio
|
Q2 2024
Reduced 0.11%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,346
shares
|
$21,353
0.0% of portfolio
|
Q2 2024
Reduced 36.76%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
8,354
shares
|
$13,366
0.0% of portfolio
|
Q3 2024
Reduced 69.7%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
2,860
shares
|
$4,576
0.0% of portfolio
|
Q3 2024
Reduced 61.27%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,851
shares
|
$4,561
0.0% of portfolio
|
Q2 2024
Reduced 20.56%
|
|
|
Aspire Private Capital, LLC
|
Oct 25, 2024 Q3 2024 |
800
shares
|
$1,280
0.0% of portfolio
|
Q4 2021
Added 100.0%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 13, 2024 Q3 2024 |
508
shares
|
$812
0.0% of portfolio
|
Q3 2024
Reduced 0.97%
|
|
|
Covestor LTD
Boston, MA |
Nov 01, 2024 Q3 2024 |
226
shares
|
$361
0.0% of portfolio
|
Q4 2023
Added 19.58%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
117
shares
|
$187
0.0% of portfolio
|
Q3 2024
Reduced 23.03%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2024 Q3 2024 |
100
shares
|
$160
0.0% of portfolio
|
Q3 2024
Reduced 61.69%
|
|
|
Planning Capital Management Corp
Paoli, PA |
Nov 06, 2024 Q3 2024 |
100
shares
|
$160
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Maryland Capital Advisors Inc.
|
Oct 22, 2024 Q3 2024 |
35
shares
|
$56
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
18
shares
|
$28
0.0% of portfolio
|
Q3 2024
Reduced 5.26%
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
14
shares
|
$22
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Sachetta, LLC
Lynnfield, MA |
Nov 08, 2024 Q3 2024 |
14
shares
|
$22
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Bfsg, LLC
|
Oct 16, 2024 Q3 2024 |
5
shares
|
$8
0.0% of portfolio
|
Q2 2024
Reduced 28.57%
|